Background: Treatment of chronic rhinosinusitis (CRS) aims to treat the underlying inflammation or infection. Although the optimal modality of administration remains controversial, inhalation route is usually preferred. The aim of this systematic review was to summarize the efficacy of intranasal corticoisteroids or antibiotics delivery by nebulization on symptoms, histology, endoscopy scores, nasal obstruction, clinical outcomes and quality of life in CRS.
Introduction
Rhinosinusitis is one of the most common reasons for visiting a general practitioner (1) . Chronic rhinosinusitis (CRS) which is defined by at least 12 weeks of persistent symptoms and signs despite maximal therapy (2) , affects 14% of the population at least once in their life and is associated with a reduced quality of life (3) . Treatment of CRS is mainly symptomatic. Medical treatment (4) is usually proposed as first line and aims to treat the underlying inflammation (1) . Corticosteroids are the most prescribed drug for treating CRS with or without polyposis (5) with a high level of evidence (2) . However, there is a low level of evidence for the efficacy of topical antibacterial therapy (2) .
Although the optimal modality of administration (oral, intranasal spray and nasal nebulization) remains controversial for corticosteroids (6) , they are usually delivered by inhalation route which offers minimal systemic side-effects (7) . This route of administration is supported by level 1A evidence (2) . Even if there is no evidence to support one intranasal delivery modality over C o r r e c t e d P r o o f the others (6) , nebulization is frequently proposed and some in vitro data suggest a possible better targeted deposition (8) . Even if others drugs were used by nebulization (9) , it's anecdotal.
The aim of this systematic review was to summarize the efficacy of intranasal delivery of corticosteroids or antibiotics by nebulization on symptoms, histology, endoscopy scores, clinical outcomes and quality of life in CRS.
Method Protocol
The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines were consulted during the stages of design, analysis, and reporting of this Systematic Review (10) .
According to these guidelines, the structured search, study selection, risk-of-bias assessment of individual studies and best-evidence-syntheses for relating risk-of bias to consistency of effect sizes were included in this review. The protocol for this review has been registered in the international prospective register of systematic reviews PROSPERO (Registration No.
CRD42017068344).

Eligibility criteria, sources and search strategy
PubMed and Scopus online databases were screened for the primary search strategy from inception to May 2017. Two key terms were combined: « *sinus* » AND « nebuli* » for the patient and intervention category, respectively.
The full search strategy for PubMed was adapted for other databases using terms and Medical Subject Headings (MeSH) combined with Boolean operators. A hand-searching reference lists from the identified articles, citation tracking of included articles, and use of the PubMed related articles option completed the database searches to avoid missing relevant studies.
Study selection and exclusion criteria
After removal of duplicates, abstracts were checked critically and independently for relevance by two independent investigators (C.D. and G.R.). Articles were included if they were research articles about studies evaluating the effects of corticosteroids or antibiotics by nebulization in sinusitis, written in English or
French and not classified as case report, review or meta-analysis.
Studies about children or animals were excluded ( Table 1) . The investigators reviewed full-text articles when inclusion or exclusion was unclear based on the title and abstract. Any disagreement about eligibility was resolved by consensus.
Data extraction, study quality appraisal and risk of bias assessment
Study details and data were extracted by two investigators (C.D.
and G.R.). Collected data for each study included the design, sample characteristics (including number of participants, age group, disease and severity and inclusion/exclusion criteria of the study), devices and drugs nebulized, clinical outcomes and results, and side effects.
The same two investigators applied the quality Index developed by Downs and Black for assessing the quality of reporting (10 items), the external validity (3 items), the bias and confounding elements (13 items) and the statistical power (1 item) of all the studies (11) . This quality index comprises 27 questions with a total maximum score of 28 (12) . A grade ranging from "poor" (<14 points) to "excellent" (24-28 points) was assigned to each study evaluated by this quality index (12) .
Data synthesis
The investigators considered the results of the studies. Descriptive results, mean comparison, side effects and adherence/completion rate were reported when available.
Results
Study selection
A total of 600 references were originally retrieved from the different databases (Figure 1 ). After duplicates removal, 506 articles were identified and screened. At the end of the process, eight RCT were included in the systematic review (13) (14) (15) (16) (17) (18) (19) (20) . (19) , Total Nasal Symptom Score (15, 24) , Lund-Kennedy Score (18) and Sino-Nasal Outcome Test (SNOT-20) (17) . The three last ones are specific to CRS. Olfaction evaluation by the Sniffin' Sticks Test (SST) and the Retro-Nasal Test (RNT) was used as outcome in one study (17) .
Nasal secretions were obtained in one study and cultured when any signs of purulence were present (22) . Endoscopic evaluations of polyps were performed by the Lund-Mackay score (15) , the Kupferberg grades (15) and the Lund-Kennedy Endoscopic scale (18) .
Acoustic rhinometry was used in one study to quantify the volume of nasal cavity and the resistance of upper airways (14) . The
Peak Nasal Inspiratory Flow (PNIF) was also used as a marker of efficacy in the same study (14) .
The quality of life was evaluated by one specific (Rhinoconjunc- 
Quality and design of the studies
The quality assessment of the reviewed studies is presented in Table 3 . The scores obtained by Downs and Black scale ranged from 14 to 23 and the median score was 19.5/28. All studies were classified as "Fair" or "Good" in the quality appraisal.
Results of the studies
All the results are reviewed in Table 4 and the main results are summarized hereunder by outcome.
Effects on symptoms
Efficacy of nasal delivery by nebulization on symptoms was observed in nearly all studies using this outcome, independently on the nebulized drug.
Nebulized corticosteroids showed a higher decrease of the total score of symptoms than saline solution nebulization even if the difference in change was not always significantly different (14, 20) .
The improvement was similar between corticosteroids nebulized and delivered by nasal spray (15) .
Out of the three studies related to the nebulization of antibiotics (13, 16, 19) , symptoms were not improved by the nebulization (13, 16, 19) .
Both drugs were nebulized concomitantly in two studies from the same team. An improvement was observed at short and long term with the nebulization and it was mainly related to the presence of polyps (18) . The effect disappeared 4 weeks after nasal spray delivery (18) .
Effects on histology
Corticosteroids reduced some inflammatory parameters but only when they are nebulized (20) . The combination of both ne-
Characteristics of the studies
The characteristics of the studies are described in Table 2 . The majority of the studies are recent (6/8 were published less than 5 years)
Population and inclusion criteria
A total of 263 patients were included from studies including 6 to 60 patients. Age ranged from 18 to 89 years. Five studies included patients with previous endoscopic surgery (13, 15, 16, 18, 19) . Naso-sinusal polyps were included in 4 studies (13, 17, 20, 21) but only one study evaluated their sizes (20) .
Interventions
All the protocols used regarding way of delivery, drugs and devices (settings and properties) were summarized in Table 2 .
Nebulization was used alone or compared with oral treatment, nasal spray, nasal irrigation or nasal gel. Nebulized antibiotics have been studied as much as nebulized corticosteroids. Only one study combined both drugs (18) . Different devices were found in the studies. Six studies used specific nebulizer to target the sinus (14, 15, 17, 20, 22) but only 4 out of them performed the administration with a sonic nebulizers (15, 17, 20, 22) . Particle size was determined in 3 studies and the mass median aerodynamic diameter varied from 3.2 to 30 µm (19, 23) .
The durations of the treatment were heterogeneous, ranging from 7 days to 17 weeks. Regarding the nebulization, the duration of the session was highly variable but often not recorded.
Outcomes
Different outcomes were analyzed in the reviewed studies.
Symptoms were evaluated in all studies. Six scales were used:
Visual Analogue Scale (VAS) (13, 16, 19) , Disease Specific Symptom with the nasal spray (18) .
Effects on endoscopic evaluation
The size of polyps decreased with the delivery of corticosteroids by nebulization (15, 20) . After treatment with budesonide, an intergroup difference was observed in favor of nebulization compared to the administration by spray (15) or placebo (20) .
After tobramycin administration, the endoscopic results improved but they were not different between nebulization and nasal spray (16) . In another study, the effect of nebulized aminoglycosides was not different from saline solution nebulization but the patients received oral antibiotics in both groups (19) .
The patients without polyps did not demonstrate a benefit of the treatment when corticosteroids and antibiotics were nebulized concomitantly (18) .
Effects on nasal obstruction
Only nebulized budesonide resulted in increased PNIF even if the change magnitude was not different compared to saline nebulization (14) . However, in the same study, no difference in rhinometry improvement was observed between budesonide and saline nebulization (14) .
Saline nebulization was better than tobramycin nebulization on nasal obstruction (16) .
Effects on quality of life
The quality of life of these patients was reduced compared to the general population (19) .
Quality of life was improved by nebulized corticosteroids but it
was not different than saline solution nebulization (14) .
No benefit was observed on quality of life after tobramycin nebulization compared to nasal spray delivery or nebulized saline solution (16, 19) .
Effects on bacteriology
No study evaluated the effects of corticosteroids on bacteriology.
One study evaluated the effect of tobramycin on cultures (13) . Efficacy on the initial bacteria was verified with eradication of 47% of strains (13) .
Side-effects
Few side effects were noted in the retrieved studies (13, 20) . The side-effects were always recovered by an adapted treatment.
Discussion
To our knowledge, this is the first systematic review to focus newly investigated, is an interesting way to treat CRS which is very frequent in the general population (3) . Globally, efficacy on symptoms, quality of life and inflammation was verified when nebulization was used as way of delivery.
Although the protocols and results related to the nebulization are not homogeneous and vary depending on the nebulized drug and the comparator, based on the different studies included in this systematic review, we can conclude that nasal nebulization offers a valuable way of treatment in CRS. Our results justify the place of the nebulization in the treatment of CRS as previously suggested by the European guidelines (2) . Moreover, the dose of corticosteroids is lower when nebulized than the administered dose with oral delivery. However, the systemic absorption of corticosteroids when topically delivered by the nose has to be evaluated and taken into account (25) even if the drug delivered by nasal route into the nose is quickly eliminated by mucociliary clearance or through the digestive tract (26) .
The efficacy of nebulized antibiotics or corticosteroids on symptoms was or tended to be significant in all studies. Indeed, symptoms decreased systematically after nebulized budesonide (14, 15, 20) . This improvement was similar to the nasal spray delivery which remains the gold standard in CRS. It highlights that the nebulization can be a potential alternative to the nasal spray as a way of administration of corticosteroids even if it is more expensive and more time-consuming. It is also an alternative to oral steroids without the risk of osteoporosis observed with this way of administration (27) . Antibiotics were efficient by nasal nebulization (13, 16, 19) and sometimes associated to side-effects (13) .
This efficiency of the nebulized antibiotics has been considered as less convincing in the past (28) . The nebulized saline alone was also efficient than nebulized tobramycin which confirms this feeling (16) . Thus they have been not recommended until now in the guidelines. The presence of polyps seems to play an important role in the response to nebulization (21) . A recent systematic review on a similar topic demonstrated also that the results depended on the presence of polyps (29) . We hypothesize that it could be explained by the impaction of the nebulized drug on the polyps. Nasal nebulization was demonstrated to deposit better below the nasal valve as compared to nasal sprays (30) (31) (32) .
However, the improvement related to the nebulized way was not different compared to the delivery by spray (15) . Similar results were found on endoscopic parameters. Nebulized corticosteroids seem even more efficient than all the other treatment. Lund-Kennedy Endoscopic Score improved with nasal nebulization of antibiotics combined to other drugs (18) .
When patients were refractory to surgical and medical therapies, nebulized tobramycin offers only a small benefit on parameters of sinonasal endoscopy (16) . It can be explained by the selected device showing inconsistent delivery into the sinuses (33) . By nebulization, budesonide demonstrated also a small but significant benefit on Kupferberg grades as compared to delivery of the same drug by nasal spray with a reduction of edema (15) . In this study, the nebulizer was specific to a sinus delivery (34) . The PNIF was improved without effect on the nasal volume (14) . As this outcome was demonstrated to be an efficient tool to detect nasal patency changes (35, 36) , it suggests improvement of nasal Surprisingly, the quality of life was evaluated in only a few studies (14, 16, 19) . The benefits were not statistically significant but they were clinically relevant in the study using RQLQ with an improvement higher than the minimal clinically important difference (0.5pts) (37) . As far as histological changes, endoscopy scores modification or nasal obstruction are concerned, the results are globally similar for all studies. Inflammatory markers were improved by nebulization of budesonide (20) .
This systematic review highlights a great disparity in the tools used between the different studies. A similar observation was mentioned in a previous systematic review on the role of corticosteroids related to surgery (29) . Moreover, some non-specific scales were found in the studies, mainly to evaluate symptoms and nasal mucosa appearance. The nebulizers differed also between studies. We found a lot of specific nebulizer in this review. Out of them few nebulizers were delivering pulsatile aerosols. Sonic nebulizers are rarely used in the retrieved studies despite they improve sinusal deposition and delivery by the nasal route as suggested by different studies (34, 38) . Moreover, the particle size of delivered aerosol varies between studies and could be not optimally adapted to the sinus delivery.
Some limits need to be addressed regarding the results of this systematic review. First, the nebulization could be influenced by a surgery since a study demonstrated a significant lower total nasal deposition after surgery (30) . The inclusion criteria in the different studies varied on this point even if the majority of the studies included patients with surgery. The delay between surgery and the experiments and mainly the kind of surgery must also be taken into account. However, it is difficult because this delay varied from 6 weeks to 3 months and the surgical protocols were poorly or not described in the studies. Secondly, the inclusion of patients with polyps in some studies could also play a role in the results as suggested previously in the discussion. Due to the heterogeneity of the inclusion criteria from the included studies related to the presence of polyps, a sub-analysis comparing CRS with and without polyps is not justified. Thirdly, the sample size is frequently too small to observe an effect. Fourthly, the control group received either saline nebulization or an administration of the same drug by nasal spray. The choice of saline as control in many studies can be questionable since nebulized saline solution improves outcomes in studies on chronic rhinosinusitis (39) and the nasal volume similarly to inhaled steroids (14) . Similar benefit than with nasal spray can be considered positive since its efficacy as a way of treatment is largely supported in CRS with or without polyposis (5, 40, 41) . Nasal spray and saline solution were mentioned as a possible treatment in the European guidelines with a high level of evidence (2, 39) . At least, other modalities were not included in this review. Even if nasal pressurized metereddose inhalers dominate the market of the devices for nasal drug delivery, other liquids formulations, nasal powder devices exist or are in development. Among these modalities were previously discussed in a paper (42) . Mini-invasive options for delivery in the sinus were also investigated (43, 44) .
Conclusions
In conclusion, this systematic review highlighted that based on the present literature nebulization is not better than nasal spray to the delivery of corticosteroids with positive results observed on symptoms, endoscopic appearance and histological outcomes. For antibiotics, the results are less convincing and the nebulization is not of added value for the nasal delivery. Further large-scale studies are required to clarify the optimal protocol for treating CRS and to perform a cost-effectiveness analysis.
